Reflections on the US FDA's Warning on Direct-to-Consumer Genetic Testing-Reference-Cited by-同舟云学术

Reflections on the US FDA's Warning on Direct-to-Consumer Genetic Testing

Published:2014 Issue:4 Volume:12 Page:151
ISSN:2234-0742
Container-title:Genomics & Informatics
language:en
Short-container-title:Genomics Inform

Author:

Yim Seon-Hee¹,Chung Yeun-Jun²

Affiliation:

1. Department of Medical Education, Integrated Research Center for Genome Polymorphism, MRC, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea.

2. Department of Microbiology, Integrated Research Center for Genome Polymorphism, MRC, College of Medicine, The Catholic University of Korea, Seoul 137-701, Korea.

Publisher

Korea Genome Organization

Subject

Health Informatics,Genetics,Ecology, Evolution, Behavior and Systematics

Reference21 articles.

1. US Food and Drug Administration. Warning letter, Nov 22, 2013. Silver Spring. US Food and Drug Administration. 2013. Accessed 2014 Oct 31. Available from: http://www.fda.gov/iceci/enforcementactions/warningletters/2013/ucm376296.htm

2. Regulation: The FDA is overcautious on consumer genomics

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. When convenience trumps quality of care: A population-based survey on direct to consumer orthodontics;American Journal of Orthodontics and Dentofacial Orthopedics;2021-05

2. Ethico-legal and Policy Issues Surrounding Personalised Medicine;SpringerBriefs in Public Health;2020-11-24

3. Lessons Learned from Direct-to-Consumer Genetic Testing;Clinics in Laboratory Medicine;2020-03

4. Third party interpretation of raw genetic data: an ethical exploration;European Journal of Human Genetics;2017-08-23

5. Direct to consumer genetic testing and the libertarian right to test;Journal of Medical Ethics;2017-08-20